From: Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy)
SSc-related complications and comorbidities | HRa | CI 95% |
---|---|---|
Acute myocardial infarction | 2.14 | 0.93–4.89 |
Subarachnoid and intracerebral haemorrhage | 2.26 | 1.32–3.87 |
Ischemic stroke events | 1.30 | 0.24–3.63 |
Congestive heart failure | 3.54 | 2.38–5.28 |
Malignant essential hypertension | 3.68 | 0.97–14.0 |
Gangrene | 2.30 | 1.27–4.14 |
Chronic ulcer of skin (except pressure ulcer) | 1.36 | 0.95–1.95 |
PAH | 2.24 | 1.41–3.55 |
Lung involvement | 1.50 | 1.06–2.11 |
Pulmonary fibrosis | 2.60 | 1.56–4.35 |
Pneumonia | 1.59 | 1.00–2.53 |
Pulmonary embolism | 1.55 | 0.55–4.35 |
Chronic kidney disease | 1.30 | 0.58–2.88 |
Acute renal failure | 2.74 | 1.62–4.63 |
Haemorrhage of gastrointestinal tract | 2.69 | 0.73–9.93 |
Intestinal obstruction (without hernia) | 3.39 | 2.03–5.66 |
Diabetes mellitus | 1.31 | 0.84–2.04 |
Gout | 1.35 | 0.94–1.95 |
Malignant neoplasm | 1.88 | 1.27–2.80 |